Digital therapeutics Market By Product Type, By Application and By Geography – Opportunities & Forecast, 2021-2028
Digital Therapeutics Market Size & Analysis Report by Type (Hardware, Software and Services), By Sales Channel (B2B and B2C), By Application (Cardiovascular Diseases, Diabetes, Neurological Disorders, Respiratory Diseases, Prediabetes, Obesity, Smoking Cessation and Others) and by Region – Global Opportunities & Forecast, 2021-2028
Published Date: Nov-2021 | Report Format: Excel/PPT | Report Code: HM46A-00-0719
1. Executive Summary
1.1. Key Market Insights
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Regional Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
2.5.1. Research Data
2.5.2. Primary Data
2.5.3. Demand Side and Supply Side Analysis
2.5.4. Market Size Estimation
2.5.5. Research Assumptions
3. Global Digital Therapeutics Market- Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Market Drivers
3.5. Market Restraints
3.6. Market Trends
4. Global Digital Therapeutics Market Revenue Forecast till 2028
5. Global Digital Therapeutics Market by Type Revenue Forecast till 2028
5.1. Hardware
5.2. Software
5.3. Services
6. Global Digital Therapeutics Market by Sales Channel Revenue Forecast till 2028
6.1. B2B
6.2. B2C
7. Global Digital Therapeutics Market by Application Revenue Forecast till 2028
7.1. Cardiovascular Diseases
7.2. Diabetes
7.3. Neurological Disorders
7.4. Respiratory Diseases
7.5. Prediabetes
7.6. Obesity
7.7. Smoking Cessation
7.8. Others
8. Global Digital Therapeutics Market by Region Forecast till 2028
8.1. North America Digital Therapeutics Market Revenue Forecast till 2028
(Option 1: As a part of the free 25% customization)
8.1.1. North America Digital Therapeutics Market by Type
8.1.1.1. Hardware
8.1.1.2. Software
8.1.1.3. Services
8.1.2. North America Digital Therapeutics Market by Sales Channel
8.1.2.1. B2B
8.1.2.2. B2C
8.1.3. North America Digital Therapeutics Market by Application
8.1.3.1. Cardiovascular Diseases
8.1.3.2. Diabetes
8.1.3.3. Neurological Disorders
8.1.3.4. Respiratory Diseases
8.1.3.5. Prediabetes
8.1.3.6. Obesity
8.1.3.7. Smoking Cessation
8.1.3.8. Others
8.1.4. US Digital Therapeutics Market All-Up
8.1.5. Canada Digital Therapeutics Market All-Up
8.2. Europe Digital Therapeutics Market Revenue Forecast till 2028
(Option 2: As a part of the free 25% customization)
8.2.1. Europe Digital Therapeutics Market by Type
8.2.1.1. Hardware
8.2.1.2. Software
8.2.1.3. Services
8.2.2. Europe Digital Therapeutics Market by Sales Channel
8.2.2.1. B2B
8.2.2.2. B2C
8.2.3. Europe Digital Therapeutics Market by Application
8.2.3.1. Cardiovascular Diseases
8.2.3.2. Diabetes
8.2.3.3. Neurological Disorders
8.2.3.4. Respiratory Diseases
8.2.3.5. Prediabetes
8.2.3.6. Obesity
8.2.3.7. Smoking Cessation
8.2.3.8. Others
8.2.4. UK Digital Therapeutics Market All-Up
8.2.5. Germany Digital Therapeutics Market All-Up
8.2.6. France Digital Therapeutics Market All-Up
8.2.7. Spain Digital Therapeutics Market All-Up
8.2.8. Rest of Europe Digital Therapeutics Market All-Up
8.3. Asia-Pacific Digital Therapeutics Market Revenue Forecast till 2028
(Option 3: As a part of the free 25% customization)
8.3.1. Asia-Pacific Digital Therapeutics Market by Type
8.3.1.1. Hardware
8.3.1.2. Software
8.3.1.3. Services
8.3.2. Asia-Pacific Digital Therapeutics Market by Sales Channel
8.3.2.1. B2B
8.3.2.2. B2C
8.3.3. Asia-Pacific Digital Therapeutics Market by Application
8.3.3.1. Cardiovascular Diseases
8.3.3.2. Diabetes
8.3.3.3. Neurological Disorders
8.3.3.4. Respiratory Diseases
8.3.3.5. Prediabetes
8.3.3.6. Obesity
8.3.3.7. Smoking Cessation
8.3.3.8. Others
8.3.4. China Digital Therapeutics Market All-Up
8.3.5. India Digital Therapeutics Market All-Up
8.3.6. Japan Digital Therapeutics Market All-Up
8.3.7. Rest of APAC Digital Therapeutics Market All-Up
8.4. RoW Digital Therapeutics Market Revenue Forecast till 2028
(Option 4: As a part of the free 25% customization)
8.4.1. RoW Digital Therapeutics Market by Type
8.4.1.1. Hardware
8.4.1.2. Software
8.4.1.3. Services
8.4.2. RoW Digital Therapeutics Market by Sales Channel
8.4.2.1. B2B
8.4.2.2. B2C
8.4.3. RoW Digital Therapeutics Market by Application
8.4.3.1. Cardiovascular Diseases
8.4.3.2. Diabetes
8.4.3.3. Neurological Disorders
8.4.3.4. Respiratory Diseases
8.4.3.5. Prediabetes
8.4.3.6. Obesity
8.4.3.7. Smoking Cessation
8.4.3.8. Others
8.4.4. Brazil Digital Therapeutics Market All-Up
8.4.5. South Africa Digital Therapeutics Market All-Up
8.4.6. Saudi Arabia Digital Therapeutics Market All-Up
8.4.7. UAE Digital Therapeutics Market All-Up
8.4.8. Rest of world (remaining countries of the LAMEA region) Digital Therapeutics Market All-Up
9. Competitive Landscape Analysis
9.1. Porter’s Five Forces Analysis
9.2. Industry – Competitive Landscape
9.3. Market Presence (Intensity Mapping)
9.4. Key Strategic Market Developments
10. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
10.1. Omada Health, Inc.
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Footprint & Employee Strength
10.1.4. Product Offerings
10.1.5. Financials
10.1.6. Key Company Developments
10.2. DarioHealth Corp.
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Footprint & Employee Strength
10.2.4. Product Offerings
10.2.5. Financials
10.2.6. Key Company Developments
10.3. Livongo
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Footprint & Employee Strength
10.3.4. Product Offerings
10.3.5. Financials
10.3.6. Key Company Developments
10.4. Welldoc’s BlueStar
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Footprint & Employee Strength
10.4.4. Product Offerings
10.4.5. Financials
10.4.6. Key Company Developments
10.5. Voluntis
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Footprint & Employee Strength
10.5.4. Product Offerings
10.5.5. Financials
10.5.6. Key Company Developments
10.6. Happify Health
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Footprint & Employee Strength
10.6.4. Product Offerings
10.6.5. Financials
10.6.6. Key Company Developments
10.7. Propeller Health
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Footprint & Employee Strength
10.7.4. Product Offerings
10.7.5. Financials
10.7.6. Key Company Developments
10.8. Kaia Health Software Inc.
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Footprint & Employee Strength
10.8.4. Product Offerings
10.8.5. Financials
10.8.6. Key Company Developments
10.9. Pear Therapeutics, Inc.
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Footprint & Employee Strength
10.9.4. Product Offerings
10.9.5. Financials
10.9.6. Key Company Developments
10.10. Akili Interactive Labs
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Footprint & Employee Strength
10.10.4. Product Offerings
10.10.5. Financials
10.10.6. Key Company Developments
11. About GMI Research
*Details on Financials might not be available in case of unlisted/private companies.
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Digital therapeutics Market By Product Type, By Application and By Geography – Opportunities & Forecast, 2021-2028
$ 4,499.00 – $ 6,649.00